Aardvark Therapeutics Inc. Common Stock

AARD | NASDAQ

$5.77

+$0.20 (+3.59%)

Sep 22, 2026, 2:18 PM ET · Market open

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022
Cash & Equivalents	47.05M	61.64M	9.74M	15.56M
Short-Term Investments	62.98M	12.02M	254K	546K
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	4.94M	2.64M	13K	14K
Receivables	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	1.86M	160K	127K	70K
Total Current Assets	111.89M	74.14M	10.37M	16.49M
Property-Plant & Equipment	355K	735K	155K	252K
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	5.3M	3.37M	168K	266K
Total Assets	117.18M	77.51M	10.54M	16.76M
Account Payables	2.07M	2.3M	1.04M	259K
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a
Other Current Liabilities	2.91M	896K	45K	53K
Total Current Liabilities	10.55M	4.93M	1.38M	595K
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	126.78M	43.91M	43.92M
Total Long-Term Liabilities	n/a	127.22M	43.96M	44.09M
Total Liabilities	10.55M	132.15M	45.34M	44.68M
Total Debt	441K	779K	162K	262K
Book Value	106.63M	-54.64M	-34.8M	-27.92M
Book Value Per Share	4.89	-2.52	-1.63	-1.31
Common Stock	n/a	n/a	n/a	n/a
Retained Earnings	-115.92M	-58.33M	-37.74M	-30.53M
Comprehensive Income	81K	n/a	n/a	n/a
Shareholders Equity	106.63M	-54.64M	-34.8M	-27.92M
Total Investments	62.98M	12.02M	254K	546K